Bio-Reference Labs downgraded to Underperform from Neutral at Macquarie Macquarie downgraded Bio-Reference Labs following the Q4 miss citing margin pressure and reimbursement cuts. Price target is $25.
News For BRLI From The Last 14 Days
Check below for free stories on BRLI the last two weeks.